• Mashup Score: 0

    Molnupiravir is now PBS-listed, but rheum patients get left behind yet again in the race for covid protection in Australia.

    Tweet Tweets with this article
    • Molnupiravir is now PBS-listed for people at high risk of severe covid, including immunocompromised, but there are concerns that rheum patients on MTX could miss out due to the high dosage criteria @KarinaBray7 https://t.co/eINyFKzful

  • Mashup Score: 0

    The TGA’s provisional approval of Australia’s first covid prevention therapy has been welcomed, but many eligible patients may miss out.

    Tweet Tweets with this article
    • Evusheld - tixagevimab and cilgavimab - given TGA provisional approval, but with only 36k treatment courses secured and 500k potential patients there are concerns about who'll miss out @ASheppeard @philipcrobinson @ProfRobBooy https://t.co/5x2sYACMZ9

  • Mashup Score: 0

    This article outlines the 2021 research outputs of OPAL Rheumatology, highlighting the collaborative efforts of OPAL’s researchers, rheumatologists and their patients

    Tweet Tweets with this article
    • OPAL dataset = 220,000 patients and 1.3 million clinical consultations from 112 Aus rheumos. 2021 research includes pt experience with biologics, anti-JAKs, biosimilars and more... @opal_ltd https://t.co/q80P17Kuk0

  • Mashup Score: 1

    A large study in early RA patients could help guide patients to make informed decisions about taking the drug and potentially increase adherence.

    Tweet Tweets with this article
    • MTX adverse events - how many and which patients get them? Large UK prospective cohort study of early RA patients starting MTX @TRacunica @KarinaBray7 https://t.co/1tUH3ac5nk

  • Mashup Score: 0

    MRI-detected tenosynovitis predicts RA developing within a year, potentially preventing overtreatment.

    Tweet Tweets with this article
    • Large imaging study finds MRI scans can help predict RA progression and could prevent overtreatment in select groups of patients with early arthritis @clarewhatson https://t.co/2cQ9wXD9wH

  • Mashup Score: 0

    Telehealth is creating health care disparities for patients who are poorer, older and culturally and linguistically diverse, researchers have found.

    Tweet Tweets with this article
    • Telehealth can create extra disadvantage for patients who are poorer, older and culturally and linguistically diverse, researchers have found. @WendyJohn8 @_connectedcare https://t.co/oMnabkV1T8

  • Mashup Score: 0

    What will 2022 hold for rheumatology clinicians and patients? New therapeutics, more real-world evidence studies and, of course, more covid.

    Tweet Tweets with this article
    • What's coming in rheumatology this year? Clinicians, researchers and patients share their predictions. @ASheppeard @CreakyJointsAus @Drbeckyg @MonaMarabani @JulianSegan @opal_ltd https://t.co/bZhlm10hIN

  • Mashup Score: 12

    The Medical Republic is offering paid internships for those keen to join our team publishing news and magazines for Australian doctors.  We have a Sydney office, but remote or hybrid internships may also be possible. Students, recent graduates and other keen applicants can express interest by emailing a CV and a writing sample to ruby@medicalrepublic.com.au…. View Article

    Tweet Tweets with this article
    • RT @frogsandstars: A little career goal of mine... finding and helping the next generation of science writers 👊https://t.co/6y4fxPKWVC